carbamazepine has been researched along with haloperidol in 137 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 46 (33.58) | 18.7374 |
1990's | 32 (23.36) | 18.2507 |
2000's | 36 (26.28) | 29.6817 |
2010's | 19 (13.87) | 24.3611 |
2020's | 4 (2.92) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Blake, JF; Curatolo, WJ; Lombardo, F | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Elshorst, B; Fiebig, K; Griesinger, C; Grimme, S; Jacobs, DM; Vogtherr, M; Zahn, R | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
Sen, S; Sinha, N | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
Ballenger, JC; Post, RM | 1 |
Bambrick, M; Wilson, D | 1 |
Codd, EE; Shank, RP | 1 |
Hartridge, C; Izawa, J; Tu, JB | 1 |
Barrelet, L; Baumann, P; Touabi, M; Uehlinger, C | 1 |
Meignan, ML | 1 |
Watts, D | 1 |
Floyd, J; Innocent, AJ; Wong, SE; Woolsey, JE | 1 |
Gastmeier, K; Hass, M; Kuteifan, K; Schott, H | 1 |
Alexander, JE; Kahn, EM; Perel, JM; Schulz, SC | 1 |
Mataga, N; Mitsushio, H; Takashima, M; Toru, M | 1 |
Diedrich, U; Müller, P | 1 |
Akamatsu, S; Kamata, N; Kawada, J; Kurata, M; Kuwae, T; Minakuchi, K; Nishida, M; Takasugi, M; Teraoka, K | 1 |
Caporali, MG; Popoli, P; Scotti de Carolis, A | 1 |
Cennamo, M; Piccione, E; Ticconi, C | 1 |
Elphick, M | 1 |
Aman, MG; Teehan, CJ; Turbott, SH; Vaithianathan, C; White, AJ | 1 |
Bäuml, J; Binz, U; Kissling, W; Möller, HJ; Riehl, T; Wendt, G | 1 |
Brown, D; Cookson, J; Silverstone, T | 1 |
Fujiwara, Y; Kazahaya, Y; Otsuki, S; Sandyk, R; Takeda, T | 1 |
Kursawe, HK; Schmickaly, R | 1 |
Chouinard, G | 1 |
Drake, ME; John, K; Kellum, JB; Pakalnis, A | 1 |
Barros, HM; Leite, JR | 2 |
Kerr, BM; Levy, RH | 1 |
Dittmar, G; Lincke, HO | 1 |
Apelt, S; Dose, M; Emrich, HM | 1 |
Cohen, LS; Heller, VL; Rosenbaum, JF | 1 |
Brayley, J; Yellowlees, P | 1 |
Caporali, MG; de Carolis, AS; Popoli, P | 1 |
Hejazi, M | 1 |
Brewerton, TD | 1 |
Fischer, W; Heydenreich, F; Rabending, G; Streubel, FR | 1 |
Gonçalves, N; Stoll, KD | 1 |
Erickson, M; Fast, DK; Jones, BD; Kusalic, M | 1 |
Arana, GW; Black, B; Friedman, H; Goff, DC; Greenblatt, DJ; Ornsteen, M; Shader, RI | 1 |
Averbuch, I; Belmaker, RH; Kidron, R; Klein, E | 1 |
Bowden, CL; Burch, NR; Davis, CM; Ereshefsky, L; Jann, MW; Saklad, SR; Seidel, DR | 1 |
Hodgman, CH; Yerevanian, BI | 1 |
Higashio, T; Inukai, T; Nakao, K | 1 |
Davidson, S; Falconer, MA | 1 |
Gazengel, J; Lhermitte, F; Marteau, R; Peterfalvi, M; Serdaru, M | 1 |
Hirata, I; Inose, T; Iwata, T; Kawajiwara, A; Tano, T | 1 |
Houpt, JL; Nelson, A; Stoudemire, A | 1 |
Foong, FW; Satoh, M | 1 |
Ciccone, JR; Kanter, GL; Yerevanian, BI | 1 |
Mori, A | 1 |
Monninger, P; Przuntek, H | 1 |
Belmaker, RH; Bental, E; Klein, E; Lerer, B | 1 |
Bear, D; Chetham, D; Geschwind, N; Levin, K; North, B; Shader, RI | 1 |
Coulter, DL; Donofrio, P | 1 |
Kellams, JJ; Klapper, MH; Marhenke, JD; Milstein, V; Small, JG; Woodham, GC | 1 |
Lemke, MR | 1 |
Agenet, C; Barges-Bertocchio, MH; Levron, JC; Pupeschi, G | 1 |
Ishikura, T; Jibiki, I; Kubota, T | 1 |
Dysken, MW; Holden, LA; Vatassery, GT | 1 |
Kerr, EE; Mowadat, HR; StClair, D | 1 |
Hosokawa, K; Iwahashi, K; Miyatake, R; Nakamura, K; Suwaki, H | 1 |
Hosokawa, K; Ichikawa, Y; Iwahashi, K; Miyatake, R; Suwaki, H | 1 |
Huang, SC; Tsai, SJ | 1 |
Iwahashi, K | 1 |
Corbett, AJ; Reid, WG; Roxanas, MG | 1 |
Campbell, M; Kafantaris, V; Lee, DO; Magee, H; Pollack, S; Samuel, R; Winny, G | 1 |
Lavrijsen, K; Zuiderwijk, PB | 1 |
Furukori, H; Inoue, Y; Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Suzuki, A; Yasui, N | 1 |
Cottencin, O; Goudemand, M; Maron, M; Rascle, C; Thomas, P; Vaiva, G | 1 |
Golay, SJ; Klapper, MH; Malloy, FW; Medlock, CE; Milstein, V; Small, JG | 1 |
Dehpour, AR; Farahani, M; Farsam, H; Sadeghipour-Roudsari, HR; Shokrgozar, AA | 1 |
Dromerick, AW; Kumar, A | 1 |
Hasfura-Buenaga, CA; Hernandez-Avila, CA; Jasso, A; Kranzler, HR; Ortega-Soto, HA | 1 |
Hirokane, G; Morita, S; Shimoda, K; Someya, T; Takahashi, S | 1 |
Berger, M; Hesslinger, B; Klose, P; Langosch, JM; Normann, C; Walden, J | 1 |
Crinella, FM; King, BH; LaHoste, GJ; Schuck, SEB; Swanson, JM; Wigal, T | 1 |
Andreatini, R; Beijamini, V; Joca, SR; Skalisz, LL; Vital, MA | 1 |
Eich, P; Fischer, R; Novakovic, M | 1 |
Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG | 1 |
Hardy-Baylé, MC | 1 |
Cardozo, J; Molina, O; Montiel, C; Mora, E; Peña, J | 1 |
Cohen, D; Diemont, WL | 1 |
Kanba, S; Miyaoka, H; Nakaki, T; Shintani, F; Suzuki, E | 1 |
Schalekamp, T | 1 |
Kreutzkamp, T; Le Comte, M; Wensveen, B | 1 |
Inoue, Y; Kaneko, S; Kondo, T; Mihara, K; Suzuki, A; Yasui-Furukori, N | 1 |
Morita, N; Suetsugu, S | 1 |
Girimaji, SC; Jairam, R; Seshadri, SP; Srinath, S | 1 |
Brennan, DM; Stewart, B | 1 |
Aggarwal, A; Aggarwal, P; Mendhekar, DN | 1 |
Cipriani, A; Geddes, JR; Rendell, JM | 1 |
Czubak, A; Glowacka, D; Kus, K; Matschay, A; Nowakowska, E | 1 |
Brodaty, H; Cumming, R; Forrester, L; Grayson, D; Hollis, J; Touyz, S | 2 |
Chen, YC; Holmes, A | 1 |
Apale, P; Appollonio, I; Capra, M; Ferrarese, C; Frigo, M; Galbussera, A; Gelosa, G; Perego, R; Tremolizzo, L | 1 |
Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S | 1 |
Brecić, P; Jukić, V; Vidović, A; Vilibić, M | 1 |
Chen, HX; Ding, XD; Huang, L; Wang, H; Wang, W; Xiao, HQ | 1 |
Azab, AN; Nassar, A; Sharon-Granit, Y | 1 |
Direk, M; Epcacan, S; Epcacan, Z; Okuyaz, C; Yildirim, DD | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
12 review(s) available for carbamazepine and haloperidol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Delirium tremens. Recent neurophysiologic concepts and therapeutic outlook].
Topics: Alcohol Withdrawal Delirium; Carbamazepine; Chlormethiazole; Clonidine; Ethanol; Haloperidol; Humans | 1992 |
[Problems of neurological drug therapy in pregnancy].
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antiparkinson Agents; Carbamazepine; Chelating Agents; Female; Fetus; Haloperidol; Humans; Nervous System Diseases; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Trimethadione; Valproic Acid | 1989 |
Clinical pharmacokinetics of carbamazepine.
Topics: Adolescent; Adult; Age Factors; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic; Drug Interactions; Half-Life; Haloperidol; Humans; Infant; Middle Aged | 1988 |
[Therapy in alcoholic delirium].
Topics: Alcohol Withdrawal Delirium; Carbamazepine; Chlormethiazole; Diazepam; Haloperidol; Humans; Phenytoin; Psychoses, Alcoholic | 1987 |
Interictal schizophrenia-like psychoses in temporal lobe epilepsy.
Topics: Anticonvulsants; Brain; Carbamazepine; Electroencephalography; Epilepsy, Temporal Lobe; Functional Laterality; gamma-Aminobutyric Acid; Haloperidol; Humans; Kindling, Neurologic; Neurocognitive Disorders; Neurotransmitter Agents; Receptors, Dopamine; Schizophrenia | 1983 |
[Recent advances in clinical psychopharmacology].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzamides; Carbamazepine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Kinetics; Lithium; Psychopharmacology; Schizophrenia | 1984 |
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid | 2001 |
[Organic solvent-related mental disorders].
Topics: Administration, Inhalation; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Haloperidol; Humans; International Classification of Diseases; Mental Recall; Psychotherapy; Self-Help Groups; Sensation; Social Support; Solvents; Substance-Related Disorders; Valproic Acid | 2003 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
17 trial(s) available for carbamazepine and haloperidol
Article | Year |
---|---|
Therapeutic effects of carbamazepine in affective illness: a preliminary report.
Topics: Adult; Affective Symptoms; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Time Factors | 1978 |
Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.
Topics: Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Lithium Carbonate; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology | 1990 |
Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.
Topics: Adolescent; Adult; Behavior Therapy; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Education of Intellectually Disabled; Epilepsy; Female; Haloperidol; Humans; Intellectual Disability; Male; Motivation; Random Allocation; Stereotyped Behavior; Thioridazine | 1989 |
Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Schizophrenia; Schizophrenic Psychology | 1989 |
Carbamazepine compared to haloperidol in acute mania.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Chlorpromazine; Female; Haloperidol; Humans; Leukocyte Count; Male; Middle Aged; Procyclidine; Psychiatric Status Rating Scales | 1989 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Lorazepam; Parkinson Disease, Secondary; Random Allocation; Schizophrenia | 1988 |
Clinical pharmacokinetics of carbamazepine.
Topics: Adolescent; Adult; Age Factors; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic; Drug Interactions; Half-Life; Haloperidol; Humans; Infant; Middle Aged | 1988 |
Carbamazepine as an adjunct of antipsychotic therapy.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Biperiden; Carbamazepine; Chlorprothixene; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1987 |
[Quantitative EEG analysis of a single dose of psychotropic drugs in healthy probands].
Topics: Adult; Arousal; Brain; Carbamazepine; Clomipramine; Desipramine; Diazepam; Electroencephalography; Evoked Potentials; Female; Haloperidol; Humans; Imipramine; Male; Psychotropic Drugs | 1986 |
[Carbamazepine in manic syndromes. A controlled double-blind study].
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Psychological Tests; Psychotic Disorders | 1985 |
Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1984 |
Lithium combined with carbamazepine or haloperidol in the treatment of mania.
Topics: Adult; Aged; Bipolar Disorder; Brief Psychiatric Rating Scale; Carbamazepine; Drug Combinations; Female; Follow-Up Studies; Haloperidol; Humans; Lithium; Male; Middle Aged; Time Factors; Treatment Outcome | 1995 |
Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamazepine; Drug Therapy, Combination; Female; Follow-Up Studies; Geriatric Assessment; Haloperidol; Hospitalization; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Agitation; Severity of Illness Index; Treatment Outcome | 1995 |
Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Neurologic Examination; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Substance Abuse Treatment Centers; Substance-Related Disorders; Treatment Outcome | 1998 |
Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Metabolic Clearance Rate; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 1999 |
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Imipramine; Lithium Carbonate; Male; Phenotype; Prospective Studies; Recovery of Function; Risperidone; Secondary Prevention; Severity of Illness Index; Valproic Acid | 2004 |
Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia.
Topics: Administration, Oral; Adult; Baclofen; Botulinum Toxins, Type A; Braces; Carbamazepine; Cross-Sectional Studies; Diazepam; Female; Follow-Up Studies; Haloperidol; Humans; Injections; Male; Middle Aged; Quality of Life; Torticollis; Trihexyphenidyl; Ultrasonography; Young Adult | 2015 |
109 other study(ies) available for carbamazepine and haloperidol
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Computation of brain-blood partitioning of organic solutes via free energy calculations.
Topics: Animals; Blood-Brain Barrier; Brain; Cattle; Cells, Cultured; Endothelium, Vascular; Membrane Lipids; Microcirculation; Molecular Conformation; Molecular Structure; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Software; Solubility; Thermodynamics | 1996 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein.
Topics: Antimalarials; Binding Sites; Chloroquine; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Peptide Fragments; Phenothiazines; Prions; Protein Structure, Secondary; Quinacrine; Recombinant Proteins; Structure-Activity Relationship | 2003 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
General discussion of drug therapy in dystonia.
Topics: Adolescent; Age Factors; Baclofen; Cannabis; Carbamazepine; Child; Child, Preschool; Dystonia Musculorum Deformans; Female; Haloperidol; Humans; Levodopa; Male; Phytotherapy; Torticollis | 1976 |
Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Orphenadrine; Recurrence; Sulpiride | 1992 |
1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
Topics: Animals; Binding Sites; Binding, Competitive; Carbamazepine; Guanidines; Haloperidol; Male; Pentazocine; Phenytoin; Piperidines; Prosencephalon; Rats; Rats, Wistar; Receptors, sigma; Stereoisomerism | 1992 |
Psychopharmacogenetic aspects of Prader-Willi syndrome.
Topics: Adolescent; Aggression; Appetite Depressants; Behavior Therapy; Carbamazepine; Combined Modality Therapy; Dextroamphetamine; Fenfluramine; Gender Identity; Haloperidol; Humans; Male; Prader-Willi Syndrome; Psychotropic Drugs; Social Behavior; Testosterone; Weight Gain | 1992 |
Alopecia and mood stabilizers: two case reports.
Topics: Adult; Alopecia; Carbamazepine; Clorazepate Dipotassium; Depressive Disorder; Female; Fluvoxamine; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Methotrimeprazine; Middle Aged; Schizophrenia; Valproic Acid | 1992 |
Neuroleptic malignant syndrome in a case of acute post-traumatic psychosis.
Topics: Antipsychotic Agents; Carbamazepine; Diagnosis, Differential; Haloperidol; Humans; Middle Aged; Neurocognitive Disorders; Neuroleptic Malignant Syndrome; Neurologic Examination; Stress Disorders, Post-Traumatic; Sulpiride | 1991 |
Applying a DRO schedule and compliance training to reduce aggressive and self-injurious behavior in an autistic man: a case report.
Topics: Adult; Aggression; Autistic Disorder; Behavior Therapy; Carbamazepine; Combined Modality Therapy; Haloperidol; Hospitalization; Humans; Male; Reinforcement Schedule; Self-Injurious Behavior; Thioridazine | 1991 |
[Pain therapy for urologic cancer patients at the Potsdam district hospital--initial results].
Topics: Aged; Amitriptyline; Analgesics; Analgesics, Opioid; Aspirin; Carbamazepine; Codeine; Dipyrone; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Indomethacin; Meperidine; Morphine; Pain; Pain Measurement; Prospective Studies; Urologic Neoplasms | 1990 |
Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders.
Topics: Animals; Body Weight; Brain Chemistry; Carbamazepine; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Haloperidol; Lithium; Male; Mood Disorders; Rats; Rats, Inbred Strains; Serotonin; Substance P; Trihexyphenidyl | 1988 |
[Severe late dyskinesia caused by neuroleptics in a young female. Follow-up and treatment].
Topics: Adolescent; Carbamazepine; Clozapine; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Haloperidol; Humans; Meclofenoxate; Neuroleptic Malignant Syndrome; Schizophrenia; Schizophrenic Psychology; Tiapamil Hydrochloride | 1989 |
Effect of lithium carbonate administration singly or in combination with some psychotropic drugs on the radioiodide uptake by mouse thyroid.
Topics: Animals; Carbamazepine; Drug Interactions; Female; Haloperidol; Imipramine; Iodides; Iodine Radioisotopes; Lithium; Lithium Carbonate; Male; Mice; Mice, Inbred Strains; Psychotropic Drugs; Sex Factors; Thyroid Gland; Thyroxine; Triiodothyronine | 1989 |
The role of the purinergic system in the control of stereotypy: relationship to D-1/D-2 dopamine receptor activity.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Benzazepines; Caffeine; Carbamazepine; Dopamine Antagonists; Drug Interactions; Electroencephalography; Haloperidol; Male; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic; Stereotyped Behavior | 1989 |
Effects of carbamazepine on dopamine function in rodents.
Topics: Animals; Apomorphine; Carbamazepine; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine; Haloperidol; Hippocampus; Male; Methamphetamine; Motor Activity; Rats; Receptors, Dopamine; Tyrosine 3-Monooxygenase | 1989 |
Inhibitory effects of carbamazepine on clonidine-induced aggressive behavior in mice.
Topics: Adenosine; Aggression; Animals; Behavior, Animal; Caffeine; Carbamazepine; Clonidine; Haloperidol; Male; Mice; Prazosin; Receptors, Cell Surface; Yohimbine | 1988 |
[Therapy of delirium tremens].
Topics: Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Anti-Bacterial Agents; Benzodiazepines; Carbamazepine; Cardiac Glycosides; Cardiomyopathy, Alcoholic; Chlormethiazole; Combined Modality Therapy; Drug Therapy, Combination; Glucocorticoids; Haloperidol; Humans; Hypnotics and Sedatives; Psychoses, Alcoholic; Vitamins | 1985 |
Forced normalization. Acute psychosis after seizure control in seven patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Haloperidol; Humans; Male; Psychotic Disorders; Succinimides; Valproic Acid | 1987 |
The effects of carbamazepine on two animal models of depression.
Topics: Animals; Carbamazepine; Depressive Disorder; Disease Models, Animal; Haloperidol; Imipramine; Male; Methamphetamine; Motivation; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Prescribing lithium for pregnant women.
Topics: Adult; Bipolar Disorder; Carbamazepine; Female; Gestational Age; Haloperidol; Humans; Infant, Newborn; Lithium; Pregnancy; Pregnancy Complications | 1988 |
An interaction between haloperidol and carbamazepine in a patient with cerebral palsy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Cerebral Palsy; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Psychoses, Substance-Induced | 1987 |
Is the purinergic system involved in the control of pathological movements?
Topics: Animals; Caffeine; Carbamazepine; Electroencephalography; Haloperidol; Male; Purines; Rabbits; Stereotyped Behavior | 1987 |
Temporal lobe epilepsy with schizophrenia.
Topics: Aged; Carbamazepine; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Female; Haloperidol; Humans; Schizophrenia, Paranoid | 1987 |
Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Humans; Leukocyte Count; Leukopenia; Lithium | 1986 |
Effects of acute and chronic carbamazepine administration on apomorphine-elicited stereotypy.
Topics: Animals; Apomorphine; Carbamazepine; Haloperidol; Male; Rats; Rats, Inbred Strains; Sleep, REM; Stereotyped Behavior | 1986 |
Effect of carbamazepine on neuroleptic plasma levels and efficacy.
Topics: Adult; Biological Availability; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Haloperidol; Humans | 1986 |
Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
Topics: Acute Disease; Adult; Aged; Carbamazepine; Chromatography, Gas; Depression, Chemical; Drug Therapy, Combination; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders | 1986 |
Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia.
Topics: Adult; Carbamazepine; Drug Interactions; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1985 |
Effects of carbamazepine on plasma haloperidol levels.
Topics: Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Haloperidol; Humans; Kinetics; Schizophrenia | 1985 |
A haloperidol-carbamazepine interaction in a patient with rapid-cycling bipolar disorder.
Topics: Bipolar Disorder; Carbamazepine; Delirium; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged | 1985 |
Antagonism of picrotoxin against the taming effect of carbamazepine on footshock induced fighting behavior in mice.
Topics: Aggression; Animals; Bicuculline; Carbamazepine; Diazepam; Electroshock; gamma-Aminobutyric Acid; Haloperidol; Lithium; Male; Mice; Pentylenetetrazole; Picrotoxin | 1985 |
Coarse features in epilepsy as a consequence of anticonvulsant therapy. Report of cases in two pairs of identical twins.
Topics: Acromegaly; Adult; Anticonvulsants; Carbamazepine; Child; Diazepam; Diseases in Twins; Epilepsy; Epilepsy, Tonic-Clonic; Ethosuximide; Face; Female; Haloperidol; Humans; Hydantoins; Male; Phenobarbital; Phenytoin; Primidone; Thiazines | 1973 |
[Pharmacological analysis of a case of postanoxic intention and action myoclonus].
Topics: 5-Hydroxytryptophan; Alcohols; Anticonvulsants; Benzoates; Carbamazepine; Chlorpromazine; Diazepam; Dibenzazepines; Dopamine; Ergotamine; Female; Haloperidol; Humans; Hypoxia, Brain; Methotrimeprazine; Methyldopa; Methysergide; Middle Aged; Myoclonus; Norepinephrine; Phenobarbital; Pyrrolidines; Stereotaxic Techniques; Sulfonamides; Tranquilizing Agents; Trihexyphenidyl | 1971 |
[Depressive condition with electroencephalographic abnormalities--contribution to differential diagnosis of endogenous depression].
Topics: Adolescent; Adult; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Depression; Diagnosis, Differential; Electroencephalography; Female; Haloperidol; Humans; Male; Psychological Tests; Sex Factors | 1969 |
Neurotransmitter-blocking agents influence antinociceptive effects of carbamazepine, baclofen, pentazocine and morphine on bradykinin-induced trigeminal pain.
Topics: Analgesics; Animals; Atropine; Baclofen; Bicuculline; Bradykinin; Carbamazepine; Haloperidol; Male; Methysergide; Morphine; Naloxone; Neurotransmitter Agents; Pentazocine; Rats; Rats, Inbred Strains; Sympatholytics; Trigeminal Neuralgia; Trigeminal Nucleus, Spinal | 1984 |
Case report of a possible interaction between neuroleptics and carbamazepine.
Topics: Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Delirium; Drug Interactions; Female; Haloperidol; Humans; Imipramine; Middle Aged; Thioridazine | 1984 |
Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Athetosis; Carbamazepine; Child; Chorea; Female; Haloperidol; Humans; Male; Middle Aged; Motor Activity; Pedigree; Phenytoin; Primidone; Valproic Acid | 1983 |
Case 2: Behavioral changes with temporal lobe epilepsy: assessment and treatment.
Topics: Adult; Carbamazepine; Electroencephalography; Epilepsy, Temporal Lobe; Female; Haloperidol; Humans; Neurocognitive Disorders; Psychological Tests | 1980 |
Haloperidol for nonkinesiogenic paroxysmal dyskinesia.
Topics: Adult; Carbamazepine; Haloperidol; Humans; Male; Movement Disorders | 1980 |
Do enzyme inducers modify haloperidol decanoate rate of release?
Topics: Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Phenobarbital; Schizophrenia | 1994 |
Three cases of alopecia areata induced by zotepine.
Topics: Adult; Alopecia; Alopecia Areata; Antipsychotic Agents; Autoimmune Diseases; Carbamazepine; Clomipramine; Depressive Disorder; Diagnosis, Differential; Dibenzothiepins; Female; Haloperidol; Humans; Middle Aged; Schizophrenia | 1993 |
Resolution of the interference from carbamazepine and diphenhydramine during reversed-phase liquid chromatographic determination of haloperidol and reduced haloperidol.
Topics: Buffers; Carbamazepine; Chromatography, High Pressure Liquid; Diphenhydramine; Haloperidol; Humans; Solvents | 1993 |
Sporadic Pick's disease in a 28-year-old woman.
Topics: Adult; Atrophy; Carbamazepine; Dementia; Electroconvulsive Therapy; Female; Frontal Lobe; Haloperidol; Humans; Long-Term Care; Pregnancy; Pregnancy Complications; Temporal Lobe; Tomography, X-Ray Computed | 1993 |
Cardiac effects of haloperidol and carbamazepine treatment.
Topics: Carbamazepine; Electrocardiography; Haloperidol; Humans; Long QT Syndrome; Prevalence; Retrospective Studies; Schizophrenia | 1996 |
The drug-drug interaction effects of haloperidol on plasma carbamazepine levels.
Topics: Anticonvulsants; Antipsychotic Agents; Binding, Competitive; Carbamazepine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Haloperidol; Humans; Mixed Function Oxygenases; Schizophrenia | 1995 |
Hyponatremia and Stevens-Johnson syndrome in a patient receiving carbamazepine.
Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Hyponatremia; Male; Neurocognitive Disorders; Stevens-Johnson Syndrome | 1995 |
Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Therapy, Combination; Electrocardiography; Female; Haloperidol; Heart Failure; Humans; Long QT Syndrome; Male; Middle Aged; Schizophrenia; Ventricular Dysfunction, Left | 1996 |
A patient with mania and photoconvulsive epilepsy.
Topics: Adolescent; Anticonvulsants; Bipolar Disorder; Brain; Carbamazepine; Drug Therapy, Combination; Electroencephalography; Female; Haloperidol; Humans; Light; Lithium; Seizures | 1996 |
Assessment of children with the overt aggression scale.
Topics: Aggression; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Female; Haloperidol; Humans; Lithium; Male; Placebos; Psychotropic Drugs; Severity of Illness Index | 1996 |
Response to Iwashashi: "significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change".
Topics: Antipsychotic Agents; Carbamazepine; Drug Interactions; Electrocardiography; Haloperidol; Humans | 1997 |
Interaction between carbamazepine and bromperidol.
Topics: Adult; Analgesics, Non-Narcotic; Antipsychotic Agents; Carbamazepine; Chromatography, High Pressure Liquid; Drug Interactions; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1997 |
Carbamazepine in the treatment of neuroleptic malignant syndrome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Depressive Disorder; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Phenothiazines | 1998 |
Topographic EEG studies of mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; Haloperidol; Humans; Lithium; Male; Middle Aged | 1998 |
Decrease in erythrocyte:plasma lithium ratio by concurrent administration of psychotropic drugs and lithium in mice.
Topics: Animals; Antipsychotic Agents; Carbamazepine; Chlorpromazine; Drug Therapy, Combination; Erythrocytes; Haloperidol; Imipramine; Lithium; Male; Mice; Prospective Studies | 1998 |
Intractable hiccups during stroke rehabilitation.
Topics: Aged; Baclofen; Carbamazepine; Cerebral Infarction; Cerebrovascular Disorders; Chlorpromazine; Dopamine Antagonists; Haloperidol; Hiccup; Humans; Incidence; Male; Middle Aged; Muscle Relaxants, Central; Pons; Retrospective Studies | 1998 |
Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.
Topics: Aged; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Monitoring; Female; Genetic Variation; Haloperidol; Humans; Immunoenzyme Techniques; Male; Middle Aged; Schizophrenia | 1999 |
Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Behavior, Animal; Carbamazepine; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Haloperidol; Neostriatum; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Up-Regulation | 2000 |
The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission.
Topics: Animals; Antidepressive Agents; Apomorphine; Carbamazepine; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Haloperidol; Male; Neurotransmitter Agents; Oxcarbazepine; Rats; Rats, Wistar; Receptors, Dopamine; Stereotypic Movement Disorder; Swimming | 2000 |
[Carbamazepine-induced SIADH with clinical signs of delirium].
Topics: Adult; Carbamazepine; Delusions; Drug Therapy, Combination; Haloperidol; Humans; Inappropriate ADH Syndrome; Klinefelter Syndrome; Male; Psychotic Disorders | 2001 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnosis, Differential; Haloperidol; Hospitalization; Humans; Iatrogenic Disease; Lithium; Neurocognitive Disorders; Schizophrenia; Syndrome; Time Factors; Valproic Acid | 1998 |
Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients.
Topics: Adolescent; Anti-Dyskinesia Agents; Antimanic Agents; Carbamazepine; Child; Chorea; Female; Follow-Up Studies; Haloperidol; Humans; Male; Prospective Studies; Treatment Outcome; Valproic Acid | 2002 |
[Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Female; Haloperidol; Humans; Psychotic Disorders | 2002 |
Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Brain; Carbamazepine; Chlorpromazine; Diazepam; Fluvoxamine; Gene Expression; Haloperidol; Isoxazoles; Lithium; Male; Maprotiline; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Zonisamide | 2002 |
[Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
Topics: Antipsychotic Agents; Carbamazepine; Drug Interactions; Haloperidol; Psychotic Disorders | 2003 |
[Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
Topics: Antipsychotic Agents; Carbamazepine; Drug Interactions; Haloperidol; Humans; Psychotic Disorders | 2003 |
Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
Topics: Adult; Aged; Analysis of Variance; Brief Psychiatric Rating Scale; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 2003 |
Auditory hallucinations after right temporal gyri resection.
Topics: Adult; Affect; Anticonvulsants; Antipsychotic Agents; Brain Injuries; Carbamazepine; Electroencephalography; Hallucinations; Haloperidol; Hematoma, Subdural, Acute; Humans; Magnetic Resonance Imaging; Male; Postoperative Complications; Psychomotor Agitation; Temporal Lobe; Tomography, X-Ray Computed | 2005 |
Classical mania associated with dengue infection.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dengue; Haloperidol; Humans; India; Male; Risk Factors | 2006 |
Some behavioural effects of carbamazepine - comparison with haloperidol.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Carbamazepine; Catalepsy; Haloperidol; Male; Maze Learning; Memory; Motor Activity; Rats; Rats, Wistar | 2007 |
Risk of death associated with antipsychotic drug dispensing in residential aged care facilities.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Comorbidity; Cross-Sectional Studies; Death, Sudden; Female; Haloperidol; Homes for the Aged; Humans; Male; Nursing Homes; Olanzapine; Risk; Valproic Acid; Veterans | 2007 |
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Cohort Studies; Dementia; Female; Haloperidol; Humans; Male; Mortality; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors; Survival Rate; Valproic Acid; Veterans; Widowhood | 2007 |
Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress.
Topics: Alcoholic Intoxication; Animals; Ataxia; Carbamazepine; Central Nervous System Depressants; Conscious Sedation; Dextromethorphan; Ethanol; Excitatory Amino Acid Agents; Fructose; Haloperidol; Hypothermia; Lamotrigine; Male; Memantine; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Oxcarbazepine; Species Specificity; Stress, Psychological; Topiramate; Triazines | 2009 |
Narrowing the window for 'senile chorea': a case with primary antiphospholipid syndrome.
Topics: Age of Onset; Aged; Anti-Dyskinesia Agents; Antibodies, Antiphospholipid; Anticonvulsants; Antiphospholipid Syndrome; Basal Ganglia; Carbamazepine; Chorea; Diagnosis, Differential; Diazepam; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Huntington Disease; Magnetic Resonance Imaging; Oxcarbazepine | 2009 |
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Cataplexy; Catatonia; Clonazepam; Combined Modality Therapy; Critical Care; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Infusions, Intravenous; Loxapine; Neuroleptic Malignant Syndrome; Psychotic Disorders; Social Adjustment; Young Adult | 2010 |
Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.
Topics: Carbamazepine; Dementia; Diazepam; Electroencephalography; Haloperidol; Hematology; Humans; Hydroxocobalamin; Male; Middle Aged; Mood Disorders; Neurology; Psychotic Disorders; Seizures; Vitamin B 12 Deficiency | 2013 |
Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats.
Topics: Animals; Carbamazepine; Dinoprostone; Encephalitis; Haloperidol; Hypothalamus; Hypothermia; Imipramine; Inflammation Mediators; Lipopolysaccharides; Lithium; Male; Neoplasm Proteins; Nucleocytoplasmic Transport Proteins; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2016 |
Efficacy of levetiracetam in the treatment of Sydenham chorea.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Chorea; Female; Haloperidol; Humans; Levetiracetam; Male; Retrospective Studies; Valproic Acid | 2020 |